EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Ajanta Pharmaceuticals Ltd.

AJANTPHARM

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

NSE: AJANTPHARMOfficial website ↗

Key metrics

Market Cap

₹35,074 cr

P/E Ratio

34.6x

P/B Ratio

9.25x

ROE

24.28%

ROCE

31.53%

Debt / Equity

0.01x

Net Margin

20.06%

Dividend Yield

200%

EPS

₹73.53

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 66.38%FII: 21.68%Public: 11.94%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Ajanta Pharmaceuticals Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.